2NE1's Park Bom Caught Smuggling Illegal Drugs Internationally

8yr ago   ·   Monday 30 Jun, 2014 - 05:23pm UTC   ·   Aysohmay   ·   1 upvote   ·   0 comments   ·   20,247 views
2NE1's Park Bom Caught Smuggling Illegal Drugs Internationally
Prosecutors have revealed that 2NE1's Park Bom was caught smuggling illegal drugs into South Korea.

According to an exclusive report from Segye Ilbo, Park Bom attempted to send 82 amphetamine pills to South Korea through the Fedex's international mailing service. The illegal drugs were found by customs at the Incheon International Airport.

The illegal smuggling of drugs occurred on October 12, 2010. The prosecutor revealed that a case against Park Bom was filed on October 19, 2010. However, for reasons still unknown, the case was suspended on November 30, 2010, allowing the idol to avoid any legal proceedings. Park Bom was not even booked in the case, so her official record doesn't reflect her criminal status.

Amphetamines are used in medical treatments in some countries due to its ability to stimulate the central nervous system. However, when abused, it can cause serious harm to the body. A Presidental Decree has banned the substance in South Korea, with cases involving it treated the same as methamphetamine in terms of sentencing due to the two's similar chemical structure and properties.

"Even if it is their first time, amphetamine smugglers are held and investigated by rule, and I cannot understand what the logic behind not even booking her case was. There are cases where drug criminals are first booked and then the cases are suspended, but I've never heard of a case where it wasn't even registered," a prosecutor experienced in drug investigations stated.

YG Entertainment has called an emergency meeting to investigate that report Segye Ilbo published. A statement will be released after their investigation has been completed.
Source: jpopasia.com
Shared by: Aysohmay
Share Tweet Report
JpopAsia   © 2022             Privacy             Terms            
By continuing to browse our site you agree to our use of cookies, Updated Privacy Policy 2.01 and Terms of Service